Sign In
Buy MRNS
$0.550
+0 (+0%)
At Close: May 09, 2025
94 Biggest Movers From Friday
09:53am, Monday, 24'th Feb 2020
Gainers
Trans World Entertainment Corporation (NASDAQ: TWMC) shares jumped 50.9% to close at $5.28 on Friday after the company disclosed that its subsidiary etailz entered into a...
33 Stocks Moving in Friday's Pre-Market Session
12:15pm, Friday, 21'st Feb 2020
Gainers
Baudax Bio, Inc. (NASDAQ: BXRX) shares rose 30% to $10.40 in pre-market trading after the company reported the FDA approval of ANJESO for management of moderate to...
Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 56'5(c)(4)
12:00am, Friday, 14'th Feb 2020
Marinus Pharmaceuticals, Inc. (MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and neuropsychiatric disorders, today announced the upcoming pr
Marinus Pharmaceuticals to Present Ganaxolone EEG Clinical Data in Status Epilepticus at the ...
12:00am, Monday, 03'rd Feb 202043 Healthcare Stocks Moving In Tuesday's After-Market Session
12:00am, Tuesday, 28'th Jan 202036 Healthcare Stocks Moving In Wednesday's After-Market Session
12:00am, Wednesday, 22'nd Jan 20203 Top-Notch “Strong Buy” Stocks Under $3
09:37am, Monday, 20'th Jan 2020
If you’re on a budget, yet in a risk-tolerant mood, it’s worth taking a look at penny stocks – companies whose shares sell for less than $5 apiece. Here you get a lot more for your money; For ex
3 Top-Notch "Strong Buy" Stocks Under $3
09:33am, Monday, 20'th Jan 2020
If you’re on a budget, yet in a risk-tolerant mood, it’s worth taking a look at penny stocks – companies whose shares sell for less than $5 apiece. Here
Marinus Provides Business Outlook for 2020
12:30pm, Monday, 13'th Jan 2020
Enrollment on-track for CDKL5 Deficiency Disorder Phase 3 readout Q3 2020 Two additional late-stage clinical trials planned to initiate in 2020 Company presentation and live.
